Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.708,17
0,34%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Scopus BioPharma Inc (SCPS) Scopus BioPharma Inc (SCPS) Notizie

SCPS

Scopus BioPharma (SCPS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCPS
DataOraFonteTitoloSimboloCompagnia
02/11/202314:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
28/06/202323:16Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
12/05/202323:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
28/04/202323:05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
14/04/202323:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
16/12/202212:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
02/12/202223:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
15/11/202223:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
10/11/202215:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
18/10/202215:25GlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
05/05/202214:30GlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
01/04/202223:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
23/03/202201:30GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
20/01/202214:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
19/01/202212:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
10/01/202214:30GlobeNewswire Inc.Scopus BioPharma Provides Update Following Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
10/01/202214:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SCPSScopus BioPharma Inc
06/01/202213:00PR Newswire (US)DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSNASDAQ:SCPSScopus BioPharma Inc
05/01/202222:51Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SCPSScopus BioPharma Inc
04/01/202212:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SCPSScopus BioPharma Inc
17/12/202114:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCPSScopus BioPharma Inc
17/12/202114:00GlobeNewswire Inc.Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyNASDAQ:SCPSScopus BioPharma Inc
07/12/202123:24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SCPSScopus BioPharma Inc
07/12/202114:30GlobeNewswire Inc.Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardNASDAQ:SCPSScopus BioPharma Inc
06/12/202113:00PR Newswire (US)Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingNASDAQ:SCPSScopus BioPharma Inc
26/11/202123:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPSScopus BioPharma Inc
22/11/202114:00GlobeNewswire Inc.Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketNASDAQ:SCPSScopus BioPharma Inc
08/11/202114:00GlobeNewswire Inc.Scopus BioPharma Announces Adjournment of Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
06/10/202121:07Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:SCPSScopus BioPharma Inc
05/10/202114:45GlobeNewswire Inc.Scopus BioPharma to Present at the LD Micro Main EventNASDAQ:SCPSScopus BioPharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCPS

La tua Cronologia

NASDAQ
BRKHW
BurTech Acquisition
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network